Expert Review of Molecular Diagnostics provides expert reviews on molecular diagnostic technologies and applied pharmacogenomics in clinical medicine. Coverage includes molecular diagnostics, ...
Individual patient data (IPD) analysis of early PSA nadir in ARASENS, LATITUDE, and TITAN: Training and validation of a novel model. Assessing genomic instability (GI) by shallow whole-genome ...
Administrative Aspects of Molecular Diagnostics—Oversight, Regulatory Approval Process, Clinical and Operational Workflows, and Payment Models The following represents disclosure information provided ...
Molecular diagnostics have transformed the detection and characterisation of Plasmodium infections, overcoming the limited sensitivity of microscopy and rapid antigen tests. By targeting parasite ...
The emergence of molecular diagnostic testing in lung cancer offers new hope for patients battling the number one cancer killer in the United States and abroad. Now, for the first time after a decade ...
Combining GoCollect® sample preparation with Co-Dx PCR technology could bring blood-based molecular testing closer to ...
Pathlight™, a personalized, tumor-informed molecular residual disease (MRD) platform, will expand Foundation Medicine’s testing capabilities Pathlight uses a proprietary combination of whole genome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results